Mechanisms involved in the regulation of bovine pulmonary vascular tone by the 5-HT 1B receptor

British Journal of Pharmacology

Volumn 159, Issue 1, 2010, Pages 188-200

  McKenzie, C ^a   Alapati, V R ^a   MacDonald, A ^a   Shaw, A M ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

5 HT 1B receptor; 5 hydroxytryptamine; BK Ca; Bradykinin; cAMP; cGMP; Isoprenaline; Pulmonary arteries; T type voltage operated calcium channels

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [2 [N [(3 BENZIMIDAZOL 2 YL)PROPYL] N METHYLAMINO]ETHYL] 6 FLUORO 1,2,3 4 TETRAHYDRO 1 ISOPROPYL 2 NAPHTHYLCYCLOPROPANECARBOXYLATE DIHYDROCHLORIDE; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; BRADYKININ; CHARYBDOTOXIN; CYCLIC GMP; ISOPRENALINE; MIBEFRADIL; N [3 [3 (DIMETHYLAMINO)ETHOXY] 4 METHOXYPHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) [1,1' BIPHENYL] 4 CARBOXAMIDE HYDROCHLORIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NITROPRUSSIDE SODIUM; NNC 550396; RITANSERIN; ROLIPRAM; SB 216641; SEROTONIN; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG; VERAPAMIL; ZAPRINAST;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DRUG EFFECT; DRUG MECHANISM; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY;

ANIMALS; CALCIUM CHANNELS, T-TYPE; CATTLE; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN;

EID: 74549226468     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00519.x     Document Type: Article

References (45)

1. Alapati VR, McKenzie C, Blair A, Kenny D, MacDonald A, Shaw AM (2007). Mechanisms of U46619- and 5-HT-induced contraction of bovine pulmonary arteries: role of chloride ions. Br J Pharmacol 151 : 1224 1234.
2. Alexander SP, Mathie A, Peters JA (2008). Guide to receptors and channels, 1st edition. Br J Pharmacol 153 : S115.
3. Alioua A, Mahajan A, Nishimaru K, Zarei MM, Stefani E, Toro L (2002). Coupling of c-Src to large conductance voltage- and Ca2+-activated K+ channels as a new mechanism of agonist-induced vasoconstriction. Proc Natl Acad Sci USA 99 : 14560 14565.
4. Archer SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ, Weir EK (1994) Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP protein kinase. Proc Natl Acad Sci USA 91 : 7583 7587.
5. Barman SA, Zhu S, White RE (2003). Protein kinase C inhibits BKCa channel activity in pulmonary arterial smooth muscle. Am J Physiol 286 : L149 L155.
6. Banes AKL, Watts SW (2001). Enhanced contraction to 5-hydroxytryptamine is not due to 'unmasking' of 5-hydroxytryptamine1B receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat. Hypertension 38 : 891 895.
7. Brayden JE (2002). Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 29 : 312 316.
8. Conti MA, Adelstein RS (1981). The relationship between calmodulin binding and phosphorylation of smooth muscle kinase by the catalytic subunit of 3′:5′-cAMP dependent protein kinase. J Biol Chem 256 : 3178 3181.
9. Egermayer P, Town GI, Peacock AJ (1999). Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax 54 : 161 168.
10. Félétou M, Vanhoutte PM (2006). EDHF the Complete Story. Taylor & Francis : New York.
11. Flynn CR, Brophy CM, Furnish EJ, Komalavilas P, Tessier D, Thresher J. et al. (2005). Transduction of phosphorylated heat shock-related protein 20, HSP20, prevents vasospasm of human umbilical artery smooth muscle. J Appl Physiol 98 (5 1836 1845.
12. Fukao M, Mason HS, Britton FC, Kenyon JL, Horowitz B, Keef KD (1999). Cyclic GMP-dependent protein kinase activates cloned BKCa channels expressed in mammalian cells by direct phosphorylation at serine 1072. J Biol Chem 274 (16 10927 10935.
13. Hervé P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P et al. (1995). Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99 : 249 254.
14. Hoyer D, Clarke DE, Fozard JR, Humphrey PPA (1994). International Union of Pharmacology Classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46 : 157 203.
15. Huang L, Keyser BM, Tagmose TM, Hansen JB, Taylor JT, Zhuang H et al. (2004). NNC55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino) ethyl)-6-fluoro-,1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: A new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 309 : 193 199.
16. 2+- activated K channels: a functional unit for regulating arterial tone. Acta Physiol Scand 164 : 577 587.
17. Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR (2001). Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension-Converging evidence using 5-HT1B-receptor knockout mice and 5-HT1B/1D-receptor antagonist GR127935. Circ Res 89 : 1231 1239.
18. Kerrick WG, Hoar PE (1981). Inhibition of smooth muscle tension by cyclic AMP-dependent protein kinase. Nature 292 : 253 255.
19. Lee MR, Li L, Kitazawa T (1997). Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 272 : 5063 5068.
20. MacLean MR (1999). Pulmonary hypertension, anorexigens and 5-hydroxytryptamine: pharmacological Synergism in action? Trends Pharmacol Sci 20 : 490 495.
21. MacLean MR, Herve P, Eddahibi S, Adnot A (2000). 5-Hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 131 : 161 168.
22. McKenzie C, MacDonald A, Shaw AM (2009). Mechanisms of U46619-induced contraction of rat pulmonary arteries in the presence and absence of the endothelium. Br J Pharmacol 157 : 581 596.
23. Minami K, Fukuzawa K, Nakaya Y, Xeng XR, Inoue I (1993). Mechanism of activation of Ca-activated K+ channel by cyclic AMP in cultured porcine coronary artery smooth muscle cells. Life Sci 53 : 1129 1135.
24. Nilsson H, Aalkjaer C (2003). Vasomotion: mechanisms and physiological importance. Mol Interv 3 : 79 89.
25. Peng W, Karwande SV, Hoildal JR, Farrukh IS (1996). Potassium currents in cultured human pulmonary arterial smooth muscle cells. J Appl Physiol 80 : 1187 1196.
26. Perez-Reyes E (2002). Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83 : 117 161.
27. Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Göthert M et al. (1997). SB-216641 and BRL-15572 - compounds to pharmacologically discriminate 5-HT1B and 5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol 356 : 312 320.
28. Quayle JM, Nelson MT, Standen NB (1997). ATP-sensitive and Inwardly Rectifying potassium channels in smooth muscle. Physiol Rev 77 : 1165 1232.
29. Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 265 : C299 C303.
30. Salter KJ, Kozlowski RZ (1995). Endothelin receptor coupling to potassium and chloride channels in isolated rat pulmonary arterial myocytes. J Pharmacol Exp Ther 279 : 1053 1062.
31. Saqueton R, Noack T, Serebryakov VN (1999). NO causes perinatal pulmonary vasodilation through K+ channel activation and intracellular calcium release. Am J Physiol 276 : L925 L932.
32. Schubert R, Noark T, Serebryabov VN (1999). Protein kinase C reduces the KCa current of rat tail artery smooth muscle cells. Am J Physiol 276 : C648 C658.
33. Shaw AM, Bunton DC, Brown T, Irvine J, MacDonald A (2000). Regulation of sensitivity to 5-hydroxytryptamine in pulmonary supernumerary but not conventional arteries by a 5-HT1D-like receptor. Eur J Pharmacol 408 : 69 82.
34. Skingle M, Beattie DT, Scopes DIC, Starkey SJ, Connor HE, Feniuk W et al. (1996). GR127935; a potent and selective 5-HT1D receptor antagonist. Behav Brain Res 73 : 157 161.
35. Soria B (1988). The biophysical basis of K channel pharmacology. In : Soria B, Ceva V (eds). Ion Channel Pharmacology. Oxford University Press : New York, 167 185.
36. Tracey A, Bunton D, Irvine J, MacDonald A, Shaw AM (2002). Relaxation to bradykinin in bovine pulmonary superunerary arteries can be mediated by both a nitric oxide-dependent and -independent mechanism. Br J Pharmacol 137 : 538 544.
37. Wang H, Dong X, Zhang X, Xing J (2001). 5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats. Acta Pharmacol Sin 22 (3 269 273.
38. Wang Q, Large WA (1992). Action of histamine on single smooth muscle cells dispersed from the rabbit pulmonary artery. J Physiol 468 : 125 139.
39. 2+ -activated Cl- currents are activated by metabolic inhibition in rat pulmonary artery smooth muscle cells. Am J Physiol 273 : C520 C530.
40. White RE, Kryman JP, El-Mowafy AM, Han G, Carrier GO (2000). cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BKCa channel activity in coronary artery smooth muscle cells. Circ Res 86 : 897 905.
41. Wu S, Zhang M, Vest PA, Bhattacharjee A, Liu L, Li M (2000). A mibefradil metabolite is a potent intracellular blocker of L-type Ca2+ currents in pancreatic β-cells. J Pharmacol Exp Ther 292 : 939 949.
42. Wu X, Somlyo AV, Somlyo AP (1996). Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphatase. Biochem Biophys Res Com 220 : 658 663.
43. Zhao YJ, Wang J, Rubin LJ, Yuan XJ (1997). Inhibition of K(V) and K(Ca) channels antagonizes NO-induced relaxation in pulmonary artery. Am J Physiol. 272 (2 Pt 2 H904 H912.
44. Zhao YJ, Wang J, Rubin LJ, Yuan XJ (1998). Roles of K+ and Cl- channels in cAMP-induced pulmonary vasodilation. Exp Lung Res. 24 (1 71 83.
45. Zhou XB, Arntz C, Kamm S, Motejlek K, Sausbier U, Wang GX et al. (2001). A molecular switch for specific stimulation of the BKCa channel by cGMP and cAMP kinase. J Biol Chem 276 (46 43239 43245.